Lipum AB (Sweden) Today
| LIPUM Stock | SEK 6.70 0.15 2.19% |
Performance0 of 100
| Odds Of DistressLess than 25
|
Lipum AB is selling for under 6.70 as of the 16th of May 2024; that is -2.19 percent decrease since the beginning of the trading day. The stock's lowest day price was 6.55. Lipum AB has about a 25 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Lipum AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of April 2024 and ending today, the 16th of May 2024. Click here to learn more.
Lipum AB , a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. The company was founded in 2010 and is headquartered in Ume, Sweden. Lipum AB is traded on Stockholm Stock Exchange in Sweden. The company has 7.65 M outstanding shares. More on Lipum AB
Moving together with Lipum Stock
| 0.82 | GENO | Genovis AB | PairCorr |
| 0.69 | HNSA | Hansa Biopharma AB | PairCorr |
| 0.65 | NANOFS | Nanoform Finland Plc | PairCorr |
Moving against Lipum Stock
| 0.65 | TRAC-B | AB Traction | PairCorr |
| 0.55 | BINV | BioInvent International | PairCorr |
| 0.55 | HAV-B | Havsfrun Investment | PairCorr |
| 0.54 | CRED-A | Creades AB | PairCorr |
| 0.46 | EGTX | Egetis Therapeutics | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lipum Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lipum AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lipum AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Lipum AB (LIPUM) is traded on Stockholm Exchange in Sweden and employs 5 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 104.07 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lipum AB's market, we take the total number of its shares issued and multiply it by Lipum AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lipum AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 7.65 M outstanding shares.
Lipum AB generates negative cash flow from operations
Check Lipum AB Probability Of Bankruptcy
Ownership AllocationLipum AB holds a total of 7.65 Million outstanding shares. Lipum AB secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 81.67 % of Lipum AB outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Lipum Ownership Details
Lipum Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Lipum AB jumping above the current price in 90 days from now is about 71.72%. The Lipum AB probability density function shows the probability of Lipum AB stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Lipum AB has a beta of -0.2338. This indicates as returns on the benchmark increase, returns on holding Lipum AB are expected to decrease at a much lower rate. During a bear market, however, Lipum AB is likely to outperform the market. Additionally, lipum AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Lipum AB to move above the current price in 90 days from now is about 71.72 (This Lipum AB probability density function shows the probability of Lipum Stock to fall within a particular range of prices over 90 days) .
Lipum AB Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Lipum AB market risk premium is the additional return an investor will receive from holding Lipum AB long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lipum AB. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Lipum AB's alpha and beta are two of the key measurements used to evaluate Lipum AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.92 | |||
| Standard Deviation | 5.05 | |||
| Variance | 25.52 | |||
| Risk Adjusted Performance | (0.01) |
Lipum Stock Against Markets
Picking the right benchmark for Lipum AB stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Lipum AB stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Lipum AB is critical whether you are bullish or bearish towards Lipum AB at a given time. Please also check how Lipum AB's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lipum AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Lipum AB Corporate Management
Elected by the shareholders, the Lipum AB's board of directors comprises two types of representatives: Lipum AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lipum. The board's role is to monitor Lipum AB's management team and ensure that shareholders' interests are well served. Lipum AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lipum AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pernilla Abrahamsson | Chief Officer | Profile | |
| Associate Lindquist | CoFounder Research | Profile | |
| Pr Hernell | CoFounder Director | Profile | |
| Marina Norberg | Chief Officer | Profile | |
| Einar Ponten | Chief Officer | Profile |
How to buy Lipum Stock?
Before investing in Lipum AB, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Lipum AB. To buy Lipum AB stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Lipum AB. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Lipum AB stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Lipum AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Lipum AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Lipum AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Lipum AB?
The danger of trading Lipum AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Lipum AB is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Lipum AB. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Lipum AB is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipum AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Lipum Stock analysis
When running Lipum AB's price analysis, check to measure Lipum AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipum AB is operating at the current time. Most of Lipum AB's value examination focuses on studying past and present price action to predict the probability of Lipum AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipum AB's price. Additionally, you may evaluate how the addition of Lipum AB to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |